COMMUNIQUÉS West-GlobeNewswire

Dr. Ernesto Aycardi Joins Xenon Pharmaceuticals as Chief Medical Officer
13/03/2018
BURNABY, British Columbia, March 13, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE ), a clinical stage biopharmaceutical company, today announced that Dr. Ernesto Aycardi will join the company as its [...]
MediWound to Host Fourth Quarter and Fiscal Year 2017 Financial Results Conference Call on March 19 at 8:30 a.m. Eastern Time
13/03/2018
YAVNE, Israel, March 13, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq: MDWD ), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn and wound management, [...]
Immunovaccine to Host Investor Event on April 10, 2018 in New York City
13/03/2018
HALIFAX, Nova Scotia, March 13, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX: IMV ) (OTCQX:IMMVF), a clinical stage immuno-oncology company, announced today that it will host an R&D Update and Investor Event for [...]
Athersys Reports Financial Results for Fourth Quarter, Full Year 2017
13/03/2018
Company also announces equity investment and binding letter of intent to expand HEALIOS K.K. collaboration, covered in a separate release Management to host conference call at 4:30 PM EDT today CLEVELAND, March 13, 2018 [...]
AveXis Enters into Licensing Agreement with Genethon
13/03/2018
CHICAGO and ÉVRY, France , March 13, 2018 (GLOBE NEWSWIRE) -- AveXis, Inc. (NASDAQ: AVXS ) and Genethon today announced they have entered into an exclusive, worldwide license agreement for in vivo gene therapy delivery [...]
GW Pharmaceuticals Announces Receipt of Notices of Allowance by the United States Patent and Trademark Office (USPTO) for Five New Epidiolex® (cannabidiol) Patents
13/03/2018
LONDON and CARLSBAD, Calif., March 13, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH ) (“GW,” “the Company” or “the Group”), a biopharmaceutical company focused on discovering, developing and [...]
Bellicum Pharmaceuticals Provides Operational Update and Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2017
13/03/2018
Recruitment completed in European BP-004 registration trial of BPX-501 and rimiducid Positive BPX-501 interim results reported in AML and primary immunodeficiencies GoCAR-T candidate BPX-601 targeting PSCA in pancreatic [...]
Vital Therapies Announces Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
- VTL-308 Enrollment Nears Completion with 147 Subjects Enrolled as of March 12 - On Track for Release of Topline Results in Third Quarter of 2018 SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. ( [...]
Supernus Announces Proposed Private Offering of $350 Million of Convertible Senior Notes
13/03/2018
ROCKVILLE, Md., March 13, 2018 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN ) (the “Company”), a specialty pharmaceutical company focused on developing and commercializing products for the treatment [...]
Sientra Reports Fourth Quarter and Full Year 2017 Financial Results
13/03/2018
Remains on Track for Full and Final FDA Approval for U.S. Manufactured Implants Received ISO 13485 Certification for Breast Implants and Tissue Expanders Advanced miraDry Integration and Optimization Strategy SANTA [...]
How to Control Oily Skin - 10 Do’s and Don’ts from Dermatologists; American Academy of Dermatology
13/03/2018
ROSEMONT, Ill., March 13, 2018 (GLOBE NEWSWIRE) -- Although oily skin can clog pores and lead to increased acne breakouts, dermatologists from the American Academy of Dermatology say oily skin also has many benefits. [...]
Crinetics Pharmaceuticals Completes $63.5 Million Series B Financing
13/03/2018
SAN DIEGO, March 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced it has completed a Series [...]
Novozymes A/S’ annual shareholders’ meeting 2018
13/03/2018
Please read the full announcement in the attached PDF 2018_08_Novozymes_annual_shareholders_meeting_EN
CROSSJECT :Information relative au nombre de droits de vote et d'actions composant le capital social
13/03/2018
Communiqué de Presse Information relative au nombre total de droits de vote et d'actions composant le capital social Dijon, le 13 mars 2018 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui [...]
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward
13/03/2018
2017: a year of very significant reinforcement of the cash position (€274M at 12.31.2017), with all programs in the Company's pipeline moving forward Financial results reflect in particular the signficiant ramp-up of [...]
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société
13/03/2018
2017 : une année marquée par un renforcement très significatif de la trésorerie (274M€ au 31.12.2017), dans un contexte de progression importante de toutes les composantes du pipeline de la Société Résultats financiers [...]
VALNEVA Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya
13/03/2018
Valneva Initiates Phase I Clinical Study to Evaluate Its Single-Shot Vaccine Candidate against Chikungunya Lyon (France), March 13, 2018 - Valneva SE, a fully integrated commercial stage biotech company focused on [...]
VALNEVA initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya
13/03/2018
Valneva initie une étude clinique de Phase I pour évaluer son candidat vaccin à injection unique contre le Chikungunya Lyon, France, 13 mars 2018 - Valneva SE ("Valneva" ou "le Groupe"), société de biotechnologie dédiée [...]
Medtronic EVP & President Hooman Hakami to Speak at Oppenheimer Healthcare Conference
13/03/2018
DUBLIN - March 13, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the Oppenheimer 28 th Annual Healthcare Conference on Tuesday, March 20, 2018, in New [...]

Pages